PT Kalbe Farma Tbk (KLBF) reaffirmed its commitment to adopting artificial intelligence (AI) technology to strengthen the foundation of the healthcare industry in Indonesia. This strategic step was taken in response to the rapid digitalization that is now the main catalyst in accelerating innovation in the healthcare sector.
PT Kalbe Farma Tbk Director, Mulia Lie, revealed that AI implementation targets not only operational efficiency, but also serves as the backbone supporting more precise research and product development. Through the integration of this technology, the company aims to create a more adaptive business ecosystem to meet the needs of modern society.
In addition to focusing on research, the use of AI at Kalbe Farma is also directed at improving overall service quality and expanding the reach of education to the wider public. This innovative step is seen as a vital effort to strengthen competitiveness while ensuring the sustainability of the company's business amidst increasingly complex industry challenges.
During a discussion on the "Closing Bell" program, Mulia Lie expressed optimism that the integration of digital technology will have a positive impact on the future development of the national healthcare industry. The focus on innovation, both organizationally and in terms of services, is believed to be the key for Kalbe Farma to maintain its market leadership while providing added value to the country's healthcare ecosystem.
